Private Equity

Deep dives into the investment strategies of the world’s top private asset managers, the advisors that serve them and the companies they run.

PE Intelligence

News From The Deal

Pills Emerge Amid Tariff Uncertainty, Activism

As the markets face tariff-related volatility, some companies, especially biotechnology and pharmaceuticals companies, are setting up or extending shareholder rights plans, known as poison pills, to discourage unsolicited bidders and activist accumulations.